title: High-dose melphalan versus melphalan plus dexamethasone for AL amyloidosis.
authors.forename: Shaji
authors.initials: S
authors.lastname: Kumar
authors.forename: Angela
authors.initials: A
authors.lastname: Dispenzieri
authors.forename: Morie A
authors.initials: MA
authors.lastname: Gertz
mesh_terms: D000686:Amyloidosis / Q000188:drug therapy* / Q000401:mortality; D003907:Dexamethasone / Q000008:administration & dosage*; D004359:Drug Therapy, Combination; D006801:Humans; D007147:Immunoglobulin Light Chains; D008558:Melphalan / Q000008:administration & dosage*; D019653:Myeloablative Agonists / Q000008:administration & dosage*; D012306:Risk
chemical_list: D007147:Immunoglobulin Light Chains; D019653:Myeloablative Agonists; D003907:Dexamethasone; D008558:Melphalan